BA
CVS icon

Ballast Advisors’s CVS Health CVS Stock Holding History

Ballast Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Sell
4,042
-41
-1% -$3.66K 0.1% 89
2026
Q1 		$293K Buy
4,083
+41
+1% +$3.16K 0.09% 93
2025
Q4 		$321K Hold
4,042
– – 0.09% 93
2025
Q3 		$305K Hold
4,042
– – 0.08% 95
2025
Q2 		$279K Hold
4,042
– – 0.08% 91
2025
Q1 		$274K Buy
+4,042
New +$242K 0.09% 91
2024
Q4 		– Sell
-4,092
Closed -$257K – 164
2024
Q3 		$257K Sell
4,092
-176
-4% -$10.3K 0.08% 99
2024
Q2 		$252K Buy
4,268
+2
+0% +$125 0.08% 100
2024
Q1 		$340K Sell
4,266
-250
-6% -$19.1K 0.11% 89
2023
Q4 		$357K Sell
4,516
-755
-14% -$53.7K 0.13% 82
2023
Q3 		$368K Sell
5,271
-623
-11% -$44.1K 0.15% 84
2023
Q2 		$407K Sell
5,894
-731
-11% -$52K 0.15% 72
2023
Q1 		$492K Sell
6,625
-1,201
-15% -$101K 0.2% 55
2022
Q4 		$729K Sell
7,826
-49
-0.6% -$4.73K 0.32% 42
2022
Q3 		$751K Buy
7,875
+2
+0% +$198 0.35% 37
2022
Q2 		$730K Sell
7,873
-21
-0.3% -$2.05K 0.33% 42
2022
Q1 		$799K Buy
7,894
+107
+1% +$11.2K 0.31% 41
2021
Q4 		$803K Sell
7,787
-164
-2% -$15.2K 0.31% 42
2021
Q3 		$675K Buy
7,951
+327
+4% +$27.4K 0.28% 41
2021
Q2 		$636K Hold
7,624
– – 0.27% 43
2021
Q1 		$574K Buy
7,624
+166
+2% +$12.1K 0.26% 46
2020
Q4 		$509K Buy
7,458
+626
+9% +$40.7K 0.26% 48
2020
Q3 		$399K Buy
6,832
+1,005
+17% +$62.5K 0.25% 54
2020
Q2 		$379K Sell
5,827
-9
-0.2% -$567 0.27% 55
2020
Q1 		$346K Buy
5,836
+169
+3% +$11.3K 0.33% 51
2019
Q4 		$421K Buy
+5,667
New +$398K 0.31% 56

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ballast Advisors's CVS Position: Q2 2026 in Review

Ballast Advisors reduced its CVS Health (CVS) stake by 1% in Q2 2026, selling an estimated $3.66K and leaving 4,042 shares worth $418K. The position accounts for 0.1% of the portfolio, ranked #89.

Ballast Advisors first reported a position in CVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $803K in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ballast Advisors held 4,042 shares of CVS Health worth $418K as of Q2 2026.
  • Ballast Advisors sold 41 CVS Health shares in Q2 2026, an estimated $3.66K.
  • CVS Health made up 0.1% of Ballast Advisors's portfolio in Q2 2026, its #89 holding.
  • Ballast Advisors first reported a position in CVS Health in Q4 2019 and has held it in 26 quarters since.
  • Ballast Advisors's CVS Health position peaked at $803K in Q4 2021.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.